Life Science News

Cloud DX supplies Virtual Care and Remote Patient Monitoring hardware and services to educate the next generation of nurses and nurse practitioners in Oregon

News in Summary

  • Cloud DX has signed an 18 month contract with University School of Nursing in Oregon
  • Company to supply its Connected Health™ hardware, services, and connectivity to educate nursing students on best-in-class virtual care systems
  • This is the ninth contract executed or deployed in Q1 2022 for Cloud DX

KITCHENER, ON / ACCESSWIRE / March 8,2022 /Cloud DX (TSXV:CDX) (OTC:CDXFF), Cloud DX, a leading Virtual Care platform, announces today the signing of an 18 month contract as the exclusive vendor for Telemedicine and Remote Patient Monitoring equipment, services, and connectivity with a University Nursing School in Portland, Oregon.

This agreement demonstrates key competitive advantages of the company's Connected Health™ offering: including easy-to-use medical devices, intuitive and flexible user interfaces, and exceedingly high user satisfaction. Two hospitals using Cloud DX platform, The Ottawa Hospital and Kingston Health Science Center, released results of recent user surveys. Each indicated that over 95% of users were satisfied or very satisfied with Connected Health™.

"Patients love our Connected Health platform and Healthcare educators do too," says Robert Kaul, CEO and Founder of Cloud DX. "Our platform lowers the burden on healthcare staff and enables nurses to be closer and more connected to their patients. With a closer circle of care, our virtual care and remote monitoring solutions improve patient outcomes, in turn reducing hospital re-admissions and lowering system costs. Agreements such as this one ensure upcoming generations of nursing students are learning to leverage Telemedicine and Remote Patient Monitoring to make healthcare better, for everyone, the Cloud DX way."

About Cloud DX

Accelerating virtual healthcare, Cloud DX is on a mission to make healthcare better for everyone. Our Connected Health TM remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home. Our partners achieve better healthcare and patient outcomes, reduce the need for hospitalization or re-admission, and reduce healthcare delivery costs through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and one of "Canada's Ten Most Prominent Telehealth Providers." In 2021, Cloud DX became an exclusive partner to Medtronic Canada.

Cloud DX Investor Site:https://ir.clouddx.com/overview/default.aspx

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Social Links

Twitter https://twitter.com/CloudDX
Facebook https://www.facebook.com/clouddxinc/
LinkedIn https://www.linkedin.com/company/cloud-dx/
Instagram https://www.instagram.com/cloud.dx/

For media inquiries please contact:

Janine Scott
Marketing Lead
888-543-0944
janine.scott@CloudDX.com

For investor inquiries please contact:

Jay Bedard
Cloud DX Investor Relations
647-881-8418
jay.bedard@CloudDX.com

SOURCE:Cloud DX Inc.



View source version on accesswire.com:
https://www.accesswire.com/692054/Cloud-DX-Signs-Contract-with-US-University-Nursing-School

News Provided by ACCESSWIRE via QuoteMedia

CDX:CA
Cloud DX partners with Sheridan College on Medical Metaverse Research and Development

Cloud DX partners with Sheridan College on Medical Metaverse Research and Development

Developing the Clinic of the Future, Cloud DX work to be supported by Sheridan College through federal grant

News in Summary

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Cloud DX Signs Contract with Paramedical Service Provider for Remote Patient Monitoring

Cloud DX Signs Contract with Paramedical Service Provider for Remote Patient Monitoring

Cloud DX chosen as Virtual Care Platform for the Ontario Paramedical Service provider, replacing existing hardware and services

Cloud DX (TSXV:CDX)(OTCQX:CDXFF) is pleased to announce a new 24-month contract with an Ontario Paramedic Service Provider enabling the client to provide Remote Patient Monitoring (RPM) across its serviceable area. Cloud DX will provide its award-winning Connected Health™ platform and support the client as it transitions from its previous remote care tools to Cloud DX's Virtual Care Platform. The client showcases how beneficial ‘Remote Care Monitoring' is for Paramedical Service providers, enabling providers to establish deeper community roots and maintain funding levels, while community members benefit from greater access to much-needed care. The client has purchased 223 Connected Health™ kits totalling ~$145,000 CAD with additional recurring fees for subscription software services. Funding for the program comes from the $82.5M Community Paramedicine for Long-Term Care program announced by the Ontario government on October 22, 2021

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Cloud DX Signs Two Contracts with US Primary Care Clinics

Cloud DX Signs Two Contracts with US Primary Care Clinics

Continued growth in US RPM as partner Maxwell Telecare signs two additional clinics in Illinois

News in Summary

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Cloud DX Signs New Palliative Contract with Ontario Healthcare Team

Cloud DX Signs New Palliative Contract with Ontario Healthcare Team

Cloud DX Signs New Palliative Contract with Ontario Healthcare Team

Healthcare team to use Connected Health™ kits to provide dignity in care for up to 85 patients

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Cloud DX Announces Closing of Private Placement

Cloud DX Announces Closing of Private Placement

Cloud DX (TSXV:CDX)(OTCQB:CDXFF), a leading North American provider of virtual care and Remote Patient Monitoring (RPM) solutions, is pleased to announce that it has closed a non-brokered private placement (the "Private Placement") of 260 units (the "Units") of the Corporation at a price of $1,000 per Unit, for gross proceeds of $260,000 (the "Offering"). Each Unit is comprised of (i) a C$1,000 principal amount unsecured convertible debenture (each, a "Debenture") and (ii) 1,430 common share purchase warrants of the Corporation (each, a "Warrant"). The Debentures will mature on January 27, 2025 (the "Maturity Date") and shall bear interest at a simple rate of 10% per annum. The principal amount of the Debentures may be converted at the election of the holder thereof into common shares in the capital of the Company ("Common Shares") at a conversion price of C$0.35 per Common Share (the "Conversion Price") at any time prior to the Maturity Date. Each Warrant entitles the holder thereof to acquire one common share of the Corporation (each, a "Common Share") at a price of C$0.50 per Common Share at any time prior to 4:30 p.m. (Toronto Time) on January 27, 2024

As consideration for services rendered in connection with the Offering, the Corporation paid to certain registered brokers a cash commission in the amount equal to $13,000 (5% of the gross proceeds of the Offering); and (ii) issued to certain registered brokers 37,142 non-transferable common share purchase warrants (the "Broker Warrants"). Each Broker Warrant entitles the holder thereof to acquire one Common Share at an exercise price of $0.35 per Common Share for a period of 24 months from the date of closing of the Private Placement.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Nano One Provides Quarterly Progress Update and Reports Q2 2022 Results

Nano One Provides Quarterly Progress Update and Reports Q2 2022 Results

TSX:NANO) (OTC PINK:NNOMF) (Frankfurt:LBMB

nano one® Materials Corp. ("nano one" or the "Company") is a clean technology company with patented processes for the low-cost, low-environmental footprint production of high-performance cathode materials used in lithium-ion batteries. nano one has filed its unaudited condensed interim consolidated financial statements (the "financial statements") and management's discussion & analysis for the second fiscal quarter ended June 30, 2022 and is pleased to provide the following highlights from Q2 2022.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
BriaCell Secures License for a Promising Novel Anti-Cancer Agent

BriaCell Secures License for a Promising Novel Anti-Cancer Agent

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company") a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, announces that it has secured an exclusive license from University of Maryland, Baltimore County (UMBC) to develop and commercialize Soluble CD80 (sCD80) as a biologic agent for the treatment of cancer.

The novel technology, originally developed by Suzanne Ostrand-Rosenberg, Ph.D., Emeritus Faculty at UMBC, and member of BriaCell's scientific advisory board, is titled "Soluble CD80 as a Therapeutic to Reverse Immune Suppression in Cancer Patients" and covered under USPN 8,956,619 B2 , USPN 9,650,429 B2 , and USPN 10,377,810 B2 . In animal models, sCD80 was well-tolerated and stopped tumor growth by potentially restoring natural anti-tumor immunity (see Lucas A Horn, et al . and Samuel T Haile et al. in collaboration with Dr. Ostrand-Rosenberg). Additionally, strong anti-tumor activity of sCD80 has been reported in multiple tumor types (see Lucas A Horn, et al .). Importantly, as demonstrated in the same studies, sCD80's unique actions may involve both awakening and boosting the immune system to recognize and destroy tumor cells.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
DGTL Holdings Inc. Reports Four New PaaS Contracts from Leading CPG Brands

DGTL Holdings Inc. Reports Four New PaaS Contracts from Leading CPG Brands

Four Brands from Two Global CPG Conglomerates Leverage Patented Data and Analytics PaaS for Analysis of Digital Advertising Sponsorships During Top Broadcasted Sporting Event in North America

DGTL Holdings Inc. (TSXV: DGTL) ("DGTL" or the "Company") is pleased to announce that its wholly owned subsidiary Engagement Labs has secured four new PaaS (Platform-as-a-Service) contracts from two global consumer packaged goods (CPG) conglomerates.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Nano One Announces Results of Annual General Meeting

Nano One Announces Results of Annual General Meeting

nano one ® Materials Corp. (TSX:NANO)(OTC PINK:NNOMF)(Frankfurt:LBMB) (the "Company"), a clean technology company with patented processes for the low-cost, low-environmental footprint production of high-performance cathode materials used in lithium-ion batteries, is pleased to announce the results of the annual general meeting of shareholders adjourned July 26, 2022, and reconvened today in Vancouver, British Columbia (the " Meeting

A total of 24,138,258 common shares were represented at the Meeting, representing 25.25% of the total issued and outstanding common shares of the Company.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Naturally Splendid Announces Proposed Consolidation and Special Meeting

Naturally Splendid Announces Proposed Consolidation and Special Meeting

Naturally Splendid Enterprises Ltd. ("Naturally Splendid" or "NSE" or the "Company") (FRANKFURT:50N) (TSXV:NSP) (OTC PINK:NSPDF) announces that it intends to consolidate its issued and outstanding common shares at a ratio of up to fifteen (15) pre-consolidation shares to one (1) post-consolidation share (the "Consolidation"). The purpose of the Consolidation is to facilitate the Company's ability to attract future financings, generate greater investor interest, and improve trading liquidity

The Company currently has 330,624,458 common shares issued and outstanding. In the event the Company proceeds with the Consolidation, as opposed to a lesser ratio, the Company anticipates there would be 22,041,631 common shares issued and outstanding.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Greenlane Renewables Announces Further Expansion in South America with New Contract Wins Totaling $13.5 Million

Greenlane Renewables Announces Further Expansion in South America with New Contract Wins Totaling $13.5 Million

~Greenlane to supply its water wash upgrading technology for two new landfill gas-to-RNG projects~

Greenlane Renewables Inc. (" Greenlane ") (TSX: GRN) (FSE: 52G) today announced that it has signed new contracts with a combined value of $13.5 million ( US$10.5 million ) for the supply of its biogas upgrading technology for two landfill gas-to-renewable natural gas ("RNG") projects in South America . Greenlane will supply two water wash upgrading systems, the largest in its product line, each capable of processing enough landfill gas to produce up to approximately 850,000 MMBTU annually of pipeline specification RNG for commercial use. The project owner and locations have not been disclosed at this time. Greenlane's order fulfillment for both projects will commence immediately.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×